Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
As our understanding of the molecular basis of neurodegenerative diseases continues to improve, the prospect of using gene therapy to treat these conditions becomes increasingly realistic. This Viewpoint article discusses initial trials of an RNA interference gene-silencing strategy to modify the expression of mutant proteins in animal models of amyotrophic lateral sclerosis, and considers the hurdles that will need to be overcome to translate this approach into the clinic.
Wilson's disease is an inherited disorder of copper metabolism caused by a mutation in the copper-transporting gene ATP7B, and it results in excessive copper accumulation in the liver and brain. In this Review, the authors provide a comprehensive description of the disease's pathogenesis and neurological clinical presentation, and discuss the diagnosis and treatment options currently available.